Both Zepotide and Wegovy are modern medications intended for addressing type 2 diabetes and promoting slimming. However, they operate through distinct pathways. Wegovy is a GLP-1 receptor area stimulator, while Retatrutide acts as a dual GIP and GLP-1 stimulator, possibly offering a larger impact on combined blood sugar management and adipose tissu